Hemosol

HML-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about HML-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
November 1, 2002
Has some problems. Cash position is down to one year. If they issue stocks to rais cash, it will dilute these shares further.
Hemosol (HML-T)
November 1, 2002
Has some problems. Cash position is down to one year. If they issue stocks to rais cash, it will dilute these shares further.
Robert Floyd
President, R A Floyd Management
Price
$1.290
Owned
Unknown
DON'T BUY
DON'T BUY
October 2, 2002
Very risky situation. May have to dilute stock by issuing more shares.
Hemosol (HML-T)
October 2, 2002
Very risky situation. May have to dilute stock by issuing more shares.
Mike Weir
Managing Director, Guardian Capital
Price
$1.130
Owned
Unknown
DON'T BUY
DON'T BUY
September 20, 2002
Could run out of cash.
Hemosol (HML-T)
September 20, 2002
Could run out of cash.
Gavin Graham
Trustee, Pointbreak ETFs
Price
$0.850
Owned
Unknown
DON'T BUY
DON'T BUY
August 20, 2002
Had delays in getting product out. A lot of cash. Risky unless you buy several small pharmaceuticals to spread the risk.
Hemosol (HML-T)
August 20, 2002
Had delays in getting product out. A lot of cash. Risky unless you buy several small pharmaceuticals to spread the risk.
Gavin Graham
Trustee, Pointbreak ETFs
Price
$1.070
Owned
Unknown
DON'T BUY
DON'T BUY
August 19, 2002
Has cash burn and has to raise money. Speculative.
Hemosol (HML-T)
August 19, 2002
Has cash burn and has to raise money. Speculative.
David Baskin
President, Baskin Wealth Management
Price
$1.030
Owned
Unknown
DON'T BUY
DON'T BUY
May 2, 2002
Have had a tough time getting approval. Competition is growing. Future is uncertain.
Hemosol (HML-T)
May 2, 2002
Have had a tough time getting approval. Competition is growing. Future is uncertain.
Bruce Cooper
Portfolio Manager, T.D. Asset
Price
$3.750
Owned
Unknown
DON'T BUY
DON'T BUY
April 29, 2002
Hard to like.
Hemosol (HML-T)
April 29, 2002
Hard to like.
Michael Smedley
Exec VP & Chief Investment Officer, Morgan Meighan & Associates
Price
$3.900
Owned
Unknown
DON'T BUY
DON'T BUY
April 25, 2002
Disappointed with their product results. High burn rate.
Hemosol (HML-T)
April 25, 2002
Disappointed with their product results. High burn rate.
Robert Floyd
President, R A Floyd Management
Price
$4.000
Owned
Unknown
DON'T BUY
DON'T BUY
April 18, 2002
Has disappointed. Not convinced about the needs for blood substitute.
Hemosol (HML-T)
April 18, 2002
Has disappointed. Not convinced about the needs for blood substitute.
Glenn Paradis, BA, CFA
Vice President & Sr Portfolio Manager, Equities, Aegon Capital Management Inc.
Price
$4.600
Owned
Unknown
DON'T BUY
DON'T BUY
April 3, 2002
Treat as a trading stock. No value right now.
Hemosol (HML-T)
April 3, 2002
Treat as a trading stock. No value right now.
David Driscoll
President & CEO, Liberty International Investment Management Inc
Price
$4.580
Owned
Unknown
DON'T BUY
DON'T BUY
April 2, 2002
Only has one drug. Needds more diversification.
Hemosol (HML-T)
April 2, 2002
Only has one drug. Needds more diversification.
Joe Connolly
Director of Resource and Trading, Cockfield Porretti Cunningham
Price
$4.620
Owned
Unknown
DON'T BUY
DON'T BUY
March 21, 2002
Approval of Hemolink was denied. No revenues or earnings.
Hemosol (HML-T)
March 21, 2002
Approval of Hemolink was denied. No revenues or earnings.
Bruce Cooper
Portfolio Manager, T.D. Asset
Price
$4.200
Owned
Unknown
DON'T BUY
DON'T BUY
March 21, 2002
Too much competition.
Hemosol (HML-T)
March 21, 2002
Too much competition.
Joe Connolly
Director of Resource and Trading, Cockfield Porretti Cunningham
Price
$4.200
Owned
Unknown
BUY
BUY
March 20, 2002
At a good price and a good buy for an aggressive investor.
Hemosol (HML-T)
March 20, 2002
At a good price and a good buy for an aggressive investor.
Rob Callander
Vice President and Portfolio Manager, Caldwell Securities
Price
$5.880
Owned
Unknown
DON'T BUY
DON'T BUY
February 19, 2002
A one trick pony. Speculative.
Hemosol (HML-T)
February 19, 2002
A one trick pony. Speculative.
David Baskin
President, Baskin Wealth Management
Price
$6.290
Owned
Unknown
Showing 16 to 30 of 78 entries